6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 1g

5-Fluoro-1H-imidazole, 95.0%, 5g

N,N'-Dimethylethylenediamine, 97.0%, 10g

2-(Piperidin-4-yl)ethane-1-sulfonic acid, 95.0%, 1g

(S)-2-Bromo-3-phenylpropan-1-ol, 97.0%, 100mg

1,1,1-Trifluoro-10-iododecane, 1g

Cyclopropyl(4-fluorophenyl)methanamine hydrochloride, 1g

6-bromo-5-methyl-1H,2H,3H-imidazo[4,5-b]pyridine-2-thione, 97%, 1g

1-Bromo-4-butylbenzene>97.0%(GC)5g

5-Methyl-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid, 95%, 1g

ROTI®Sep 1086 mouse, 100 ml

4-Hydroxycyclohexyl methacrylate, 97% (stabilized with TBC), 25g

4-Nitro-(2-bromo-1,1-difluoroethyl)-benzene, 98.0%, 1g